NASDAQ 
Janus Henderson Group PLC boosted its stake in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 7.0% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 7,846 ...
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings. Enable or Disable Cookies If you disable this cookie, we will not be able to ...
For Immediate Release Chicago, IL – May 22, 2025 – Today, Zacks Equity Research discusses Insulet...
This Score can pinpoint good times to build a position in a stock, using factors like one-week price change and the monthly percentage change in earnings...
INSULET CORP has an Investment Rating of BUY; a target price of $360.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength ...
Wolfe Research upgraded shares of Insulet (NASDAQ:PODD – Free Report) from a peer perform rating to an outperform rating in a research note published on Tuesday morning, MarketBeat reports.
Citi shuffles MedTech stocks: BDX downgraded, ITGR raised; reiterates top pick
On Friday, Bernstein analysts increased their price target on Insulet (NASDAQ:PODD) Corporation...
COVENTRY – Coventry Public Schools showcased a few of its talented students during a statewide choral festival, celebrating collaborative music-making. The event, “Make Something Festival,” ...
Diabetes technology stocks have seen investor worries all but "vanish" over the possible negative...
